<DOC>
	<DOCNO>NCT02314208</DOCNO>
	<brief_summary>The purpose project study efficacy three candidate molecule ( Xenbilox , Tahor Resveratrol ) order decrease production oxysterols reduce synthesis cholesterol and/or regulate production bile acid and/or enable neuroprotective action within motor neuron .</brief_summary>
	<brief_title>Therapeutic Metabolic Intervention Patients With Spastic Paraplegia SPG5</brief_title>
	<detailed_description>The primary objective study : - decrease accumulation metabolites negative impact neurological systemic function patient SPG5 . The secondary objective study : - confirm clinical biological tolerance different candidate molecule study - improve serum bile acid profile patient SPG5</detailed_description>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Paraplegia</mesh_term>
	<mesh_term>Spastic Paraplegia , Hereditary</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<mesh_term>Chenodeoxycholic Acid</mesh_term>
	<criteria>patient confirm genetic testing status carrier 2 mutation CYP7B1 gene age â‰¥ 18 year patient sign informed consent form presence health care coverage know hypersensitvity chenodeoxycholic acid , atorvastatin , resveratrol byproduct cholesterol lower medication study treatment hepatic failure transaminases &gt; 3 time normal level progressive biliary pathology chronic diarrhea serious mental illness significant comorbid neurological disorder incapacity understand information protocol unwilling unable participate part study participation another clinical trial study period person deprive liberty judicial administrative decision adult subject legal protection unable consent pregnant breastfeed woman lack health care coverage absence sign informed consent form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>spastic paraplegia</keyword>
	<keyword>metabolism</keyword>
	<keyword>oxysterols</keyword>
	<keyword>neurogenetics</keyword>
</DOC>